FOX01 inhibitor program (Weill Cornell Medicine/Forkhead Biotherapeutics)

N/A

Report date: 2025/03/20 15:10:54
NME

Base Information

Drug NameFOX01 inhibitor program (Weill Cornell Medicine/Forkhead Biotherapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionForkhead box protein O1 inhibitors
TargetsForkhead box protein O1
Therapy Area/IndicationsDiabetes Mellitus, Type 1Lymphoma, Mantle-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWeill Cornell Medicine
China Registration ClassN/A

Develop Information

Active CompaniesForkhead BioTherapeutics IncWeill Cornell Medicine
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Lymphoma, Mantle-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A